Abstract
One of the cancer molecular hallmarks is a deviant energetic metabolism, known as the Warburg effect, whereby the rate of glucose uptake is significantly increased and a high rate of glycolysis and lactic acid production occurs even when oxygen is present—“aerobic lactatogenesis”. Accordingly, GLUT1 and MCT1, which are the main glucose and lactate transporters in cancer cells, respectively, have been proposed as oncogenes and are currently seen as potential therapeutic targets in cancer treatment. Polyphenols, commonly contained in fruits and vegetables, have long been associated with a protective role against cancer. Generally considered as nontoxic, dietary polyphenols are considered ideal chemopreventive and possibly chemotherapeutic agents. Several mechanisms of action of polyphenols in breast cancer cells have been proposed including modulation of intracellular signaling, induction of apoptosis through redox regulation or modulation of epigenetic alterations. Additionally, in vitro studies have shown that several polyphenols act as specific inhibitors of glucose transport in breast cancer cell lines and an association between their anticarcinogenic effect and inhibition of glucose cellular uptake has been described. Also, some polyphenols were found to inhibit lactate transport. Importantly, some polyphenols behave as inhibitors of both glucose and lactate cellular uptake by breast cancer cells and these compounds are thus very interesting in the context of a chemopreventive effect, because they deplete breast cancer cells of their two most important energy suppliers. So, the antimetabolic effect of polyphenols should be regarded as a mechanism of action contributing to their chemopreventive/chemotherapeutic potential in relation to breast cancer.
Similar content being viewed by others
References
Visioli F, Lastra CADL, Andres-Lacueva C, Aviram M, Calhau C, Cassano A, D’Archivio M, Faria A, Favé G, Fogliano V, Llorach R, Vitaglione P, Zoratti M, Edeas M (2011) Polyphenols and human health: a prospectus. Crit Rev Food Sci Nutr 51(6):524–546. doi:10.1080/10408391003698677
Thakur VS, Gupta K, Gupta S (2012) The chemopreventive and chemotherapeutic potentials of tea polyphenols. Curr Pharm Biotechnol 13(1):191–199. doi:10.2174/138920112798868584#sthash.2KlFWQ35.dpuf
Son TG, Camandola S, Mattson MP (2008) Hormetic dietary phytochemicals. NeuroMol Med 10(4):236–246. doi:10.1007/s12017-008-8037-y
Orena S, Owen J, Jin F, Fabian M, Gillitt ND, Zeisel SH (2015) Extracts of fruits and vegetables activate the antioxidant response element in IMR-32 cells. J Nutr 145(9):2006–2011. doi:10.3945/jn.115.216705
Vriend J, Reiter RJ (2015) The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome. Mol Cell Endocrinol 401:213–220. doi:10.1016/j.mce.2014.12.013
Upadhyay S, Dixit M (2015) Role of polyphenols and other phytochemicals on molecular signaling. Oxid Med Cell Longev 2015:504253. doi:10.1155/2015/504253
Izzi V, Masuelli L, Tresoldi I, Sacchetti P, Modesti A, Galvano F, Bei R (2012) The effects of dietary flavonoids on the regulation of redox inflammatory networks. Front Biosci (Landmark Ed) 17:2396–2418
Cojocneanu Petric R, Braicu C, Raduly L, Zanoaga O, Dragos N, Monroig P, Dumitrascu D, Berindan-Neagoe I (2015) Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers. OncoTargets Ther 8:2053–2066. doi:10.2147/ott.s83597
Szablewski L (2013) Expression of glucose transporters in cancers. Biochim Biophys Acta 1835(2):164–169. doi:10.1016/j.bbcan.2012.12.004
Wright EM, Loo DD, Hirayama BA (2011) Biology of human sodium glucose transporters. Physiol Rev 91(2):733–794. doi:10.1152/physrev.00055.2009
Wright EM, Turk E (2004) The sodium/glucose cotransport family SLC5. Pflugers Arch 447(5):510–518. doi:10.1007/s00424-003-1063-6
Birnbaum MJ, Haspel HC, Rosen OM (1986) Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein. Proc Natl Acad Sci USA 83(16):5784–5788
Zhang D, Li J, Wang F, Hu J, Wang S, Sun Y (2014) 2-Deoxy-d-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Lett 355(2):176–183. doi:10.1016/j.canlet.2014.09.003
Ortega AD, Sanchez-Arago M, Giner-Sanchez D, Sanchez-Cenizo L, Willers I, Cuezva JM (2009) Glucose avidity of carcinomas. Cancer Lett 276(2):125–135. doi:10.1016/j.canlet.2008.08.007
Dhup S, Dadhich RK, Porporato PE, Sonveaux P (2012) Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr Pharm Des 18(10):1319–1330. doi:10.2174/138161212799504902
Lieberman M, Marks A (2009) Generation of ATP from glucose: glycolysis. In: Marks’ basic medical biochemistry: a clinical approach, 3rd edn. Lippincoyt Williams and Wilkins, Philadelphia, pp 402–417
Warburg O (1956) On the origin of cancer cells. Science 123(3191):309–314
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. doi:10.1016/j.cell.2011.02.013
Aykin-Burns N, Ahmad IM, Zhu Y, Oberley LW, Spitz DR (2009) Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J 418(1):29–37. doi:10.1042/BJ20081258
Ganapathy V, Thangaraju M, Prasad PD (2009) Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 121(1):29–40. doi:10.1016/j.pharmthera.2008.09.005
Macheda ML, Rogers S, Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202(3):654–662. doi:10.1002/jcp.20166
Pinheiro C, Sousa B, Albergaria A, Paredes J, Dufloth R, Vieira D, Schmitt F, Baltazar F (2011) GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Histol Histopathol 26(10):1279–1286
Rodriguez-Enriquez S, Marin-Hernandez A, Gallardo-Perez JC, Carreno-Fuentes L, Moreno-Sanchez R (2009) Targeting of cancer energy metabolism. Mol Nutr Food Res 53(1):29–48. doi:10.1002/mnfr.200700470
Medina RA, Owen GI (2002) Glucose transporters: expression, regulation and cancer. Biol Res 35(1):9–26
Furuta E, Okuda H, Kobayashi A, Watabe K (2010) Metabolic genes in cancer: their roles in tumor progression and clinical implications. Biochim Biophys Acta 1805(2):141–152. doi:10.1016/j.bbcan.2010.01.005
Lopez-Lazaro M (2008) The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med Chem 8(3):305–312. doi:10.2174/187152008783961932#sthash.5ri1yR5h.dpuf
Grover-McKay M, Walsh SA, Seftor EA, Thomas PA, Hendrix MJ (1998) Role for glucose transporter 1 protein in human breast cancer. Pathol Oncol Res 4(2):115–120
Krzeslak A, Wojcik-Krowiranda K, Forma E, Jozwiak P, Romanowicz H, Bienkiewicz A, Brys M (2012) Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers. Pathol Oncol Res 18(3):721–728. doi:10.1007/s12253-012-9500-5
Zamora-Leon SP, Golde DW, Concha II, Rivas CI, Delgado-Lopez F, Baselga J, Nualart F, Vera JC (1996) Expression of the fructose transporter GLUT5 in human breast cancer. Proc Natl Acad Sci USA 93(5):1847–1852
Stackhouse BL, Williams H, Berry P, Russell G, Thompson P, Winter JL, Kute T (2005) Measurement of glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer. Breast Cancer Res Treat 93(3):247–253. doi:10.1007/s10549-005-5158-y
Guedes M, Araujo JR, Correia-Branco A, Gregorio I, Martel F, Keating E (2016) Modulation of the uptake of critical nutrients by breast cancer cells by lactate: impact on cell survival, proliferation and migration. Exp Cell Res. doi:10.1016/j.yexcr.2016.01.008
Harmon AW, Patel YM (2004) Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation. Breast Cancer Res Treat 85(2):103–110. doi:10.1023/B:BREA.0000025397.56192.e2
Moreira L, Araujo I, Costa T, Correia-Branco A, Faria A, Martel F, Keating E (2013) Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism. Exp Cell Res 319(12):1784–1795. doi:10.1016/j.yexcr.2013.05.001
Garrido P, Moran J, Alonso A, Gonzalez S, Gonzalez C (2013) 17beta-estradiol activates glucose uptake via GLUT4 translocation and PI3 K/Akt signaling pathway in MCF-7 cells. Endocrinology 154(6):1979–1989. doi:10.1210/en.2012-1558
Medina RA, Meneses AM, Vera JC, Guzman C, Nualart F, Astuya A, Garcia MA, Kato S, Carvajal A, Pinto M, Owen GI (2003) Estrogen and progesterone up-regulate glucose transporter expression in ZR-75-1 human breast cancer cells. Endocrinology 144(10):4527–4535. doi:10.1210/en.2003-0294
Yang Y, Wolfram J, Boom K, Fang X, Shen H, Ferrari M (2013) Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells. Cell Biochem Funct 31(5):374–379. doi:10.1002/cbf.2905
Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S, Konishi H, Karakas B, Blair BG, Lin C, Peters BA, Velculescu VE, Park BH (2004) The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther 3(8):772–775
Knobbe CB, Merlo A, Reifenberger G (2002) Pten signaling in gliomas. Neuro-Oncology 4(3):196–211. doi:10.1093/neuonc/4.3.196
Pedrero JM, Carracedo DG, Pinto CM, Zapatero AH, Rodrigo JP, Nieto CS, Gonzalez MV (2005) Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma. Int J Cancer 114(2):242–248. doi:10.1002/ijc.20711
Yang L, Wu X, Wang Y, Zhang K, Wu J, Yuan YC, Deng X, Chen L, Kim CC, Lau S, Somlo G, Yen Y (2011) FZD7 has a critical role in cell proliferation in triple negative breast cancer. Oncogene 30(43):4437–4446. doi:10.1038/onc.2011.145
Garrido P, Osorio FG, Moran J, Cabello E, Alonso A, Freije JM, Gonzalez C (2015) Loss of GLUT4 induces metabolic reprogramming and impairs viability of breast cancer cells. J Cell Physiol 230(1):191–198. doi:10.1002/jcp.24698
Purcell SH, Aerni-Flessner LB, Willcockson AR, Diggs-Andrews KA, Fisher SJ, Moley KH (2011) Improved insulin sensitivity by GLUT12 overexpression in mice. Diabetes 60(5):1478–1482. doi:10.2337/db11-0033
Stuart CA, Howell ME, Zhang Y, Yin D (2009) Insulin-stimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle. J Clin Endocrinol Metab 94(9):3535–3542. doi:10.1210/jc.2009-0162
Rogers S, Macheda ML, Docherty SE, Carty MD, Henderson MA, Soeller WC, Gibbs EM, James DE, Best JD (2002) Identification of a novel glucose transporter-like protein-GLUT-12. Am J Physiol Endocrinol Metab 282(3):E733–E738
Martel F, Monteiro R, Calhau C (2010) Effect of polyphenols on the intestinal and placental transport of some bioactive compounds. Nutr Res Rev 23(1):47–64. doi:10.1017/s0954422410000053
Jaroszewski JW, Kaplan O, Cohen JS (1990) Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies. Cancer Res 50(21):6936–6943
Kanwar U, Kaur R, Chadha S, Sanyal S (1990) Gossypol-induced inhibition of glucose uptake in human ejaculated spermatozoa may be mediated by lipid peroxidation. Contraception 42(5):573–587
Nakamura M, Ikeda M, Okinaga S, Arai K (1988) Metabolism of round spermatids in the rat: effect of gossypol on the glucose transport. Andrologia 20(5):411–416
Perez A, Ojeda P, Valenzuela X, Ortega M, Sanchez C, Ojeda L, Castro M, Carcamo JG, Rauch MC, Concha II, Rivas CI, Vera JC, Reyes AM (2009) Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol. Am J Physiol Cell Physiol 297(1):C86–C93. doi:10.1152/ajpcell.00501.2008
Lim HA, Kim JH, Kim JH, Sung MK, Kim MK, Park JH, Kim JS (2006) Genistein induces glucose-regulated protein 78 in mammary tumor cells. J Med Food 9(1):28–32. doi:10.1089/jmf.2006.9.28
Jung KH, Lee JH, Thien Quach CH, Paik JY, Oh H, Park JW, Lee EJ, Moon SH, Lee KH (2013) Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1alpha activation. J Nucl Med 54(12):2161–2167. doi:10.2967/jnumed.112.115436
Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V, Marchelli R (2005) Bioavailability of trans-resveratrol from red wine in humans. Mol Nutr Food Res 49(5):495–504. doi:10.1002/mnfr.200500002
Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomark Prev 16(6):1246–1252. doi:10.1158/1055-9965.EPI-07-0022
Azevedo C, Correia-Branco A, Araujo JR, Guimaraes JT, Keating E, Martel F (2015) The chemopreventive effect of the dietary compound kaempferol on the MCF-7 human breast cancer cell line is dependent on inhibition of glucose cellular uptake. Nutr Cancer 67(3):504–513. doi:10.1080/01635581.2015.1002625
Hernandez JF, Uruena CP, Cifuentes MC, Sandoval TA, Pombo LM, Castaneda D, Asea A, Fiorentino S (2014) A Petiveria alliacea standardized fraction induces breast adenocarcinoma cell death by modulating glycolytic metabolism. J Ethnopharmacol 153(3):641–649. doi:10.1016/j.jep.2014.03.013
Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11):891–899. doi:10.1038/nrc1478
Webb BA, Chimenti M, Jacobson MP, Barber DL (2011) Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer 11(9):671–677. doi:10.1038/nrc3110
Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, Gottfried E, Schwarz S, Rothe G, Hoves S, Renner K, Timischl B, Mackensen A, Kunz-Schughart L, Andreesen R, Krause SW, Kreutz M (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109(9):3812–3819. doi:10.1182/blood-2006-07-035972
Icard P, Lincet H (2012) A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells. Biochim Biophys Acta 1826(2):423–433. doi:10.1016/j.bbcan.2012.07.001
Lu H, Forbes RA, Verma A (2002) Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277(26):23111–23115. doi:10.1074/jbc.M202487200
Beckert S, Farrahi F, Aslam RS, Scheuenstuhl H, Königsrainer A, Hussain MZ, Hunt TK (2006) Lactate stimulates endothelial cell migration. Wound Repair Regen 14(3):321–324. doi:10.1111/j.1743-6109.2006.00127.x
Halestrap AP, Price NT (1999) The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 343(Pt 2):281–299
Wilson MC, Meredith D, Fox JEM, Manoharan C, Davies AJ, Halestrap AP (2005) Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4—the ancillary protein for the insensitive MCT2 is embigin (gp70). J Biol Chem 280(29):27213–27221. doi:10.1074/jbc.M411950200
Dimmer KS, Friedrich B, Lang F, Deitmer JW, Bröer S (2000) The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J 350(1):219–227. doi:10.1042/bj3500219
Ullah MS, Davies AJ, Halestrap AP (2006) The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1 alpha-dependent mechanism. J Biol Chem 281(14):9030–9037. doi:10.1074/jbc.M511397200
Halestrap AP (2013) The SLC16 gene family—structure, role and regulation in health and disease. Mol Aspects Med 34(2–3):337–349. doi:10.1016/j.mam.2012.05.003
Halestrap AP, Meredith D (2004) The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447(5):619–628. doi:10.1007/s00424-003-1067-2
Colen CB, Seraji-Bozorgzad N, Marples B, Galloway MP, Sloan AE, Mathupala SP (2006) Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study. Neurosurgery 59(6):1313–1323. doi:10.1227/01.NEU.0000249218.65332.BF (discussion 1323–1324)
Colen CB, Shen Y, Ghoddoussi F, Yu P, Francis TB, Koch BJ, Monterey MD, Galloway MP, Sloan AE, Mathupala SP (2011) Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study. Neoplasia 13(7):620–632
Jones NP, Schulze A (2012) Targeting cancer metabolism—aiming at a tumour’s sweet-spot. Drug Discov Today 17(5–6):232–241. doi:10.1016/j.drudis.2011.12.017
Mathupala SP, Colen CB, Parajuli P, Sloan AE (2007) Lactate and malignant tumors: a therapeutic target at the end stage of glycolysis. J Bioenerg Biomembr 39(1):73–77. doi:10.1007/s10863-006-9062-x
Mathupala SP, Parajuli P, Sloan AE (2004) Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study. Neurosurgery 55(6):1410–1419. doi:10.1227/01.NEU.0000143034.62913.59 (discussion 1419)
Sonveaux P, Végran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Investig 118(12):3930–3942. doi:10.1172/JCI36843
Fang J, Quinones QJ, Holman TL, Morowitz MJ, Wang Q, Zhao H, Sivo F, Maris JM, Wahl ML (2006) The H + -linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. Mol Pharmacol 70(6):2108–2115. doi:10.1124/mol.106.026245
Koukourakis MI, Giatromanolaki A, Bougioukas G, Sivridis E (2007) Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma. Cancer Biol Ther 6(9):1476–1479
Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E (2006) Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 66(2):632–637. doi:10.1158/0008-5472.can-05-3260
Pinheiro C, Albergaria A, Paredes J, Sousa B, Dufloth R, Vieira D, Schmitt F, Baltazar F (2010) Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 56(7):860–867. doi:10.1111/j.1365-2559.2010.03560.x
Pinheiro C, Longatto-Filho A, Azevedo-Silva J, Casal M, Schmitt FC, Baltazar F (2012) Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr 44(1):127–139. doi:10.1007/s10863-012-9428-1
Pinheiro C, Longatto-Filho A, Ferreira L, Pereira SM, Etlinger D, Moreira MA, Jube LF, Queiroz GS, Schmitt F, Baltazar F (2008) Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma. Int J Gynecol Pathol 27(4):568–574. doi:10.1097/PGP.0b013e31817b5b40
Pinheiro C, Longatto-Filho A, Scapulatempo C, Ferreira L, Martins S, Pellerin L, Rodrigues M, Alves VA, Schmitt F, Baltazar F (2008) Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch 452(2):139–146. doi:10.1007/s00428-007-0558-5
Pinheiro C, Longatto-Filho A, Simoes K, Jacob CE, Bresciani CJ, Zilberstein B, Cecconello I, Alves VA, Schmitt F, Baltazar F (2009) The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer. Eur J Cancer 45(13):2418–2424. doi:10.1016/j.ejca.2009.06.018
de Oliveira AT, Pinheiro C, Longatto-Filho A, Brito MJ, Martinho O, Matos D, Carvalho AL, Vazquez VL, Silva TB, Scapulatempo C, Saad SS, Reis RM, Baltazar F (2012) Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs). J Bioenerg Biomembr 44(1):171–178. doi:10.1007/s10863-012-9408-5
Baltazar F, Pinheiro C, Morais-Santos F, Azevedo-Silva J, Queiros O, Preto A, Casal M (2014) Monocarboxylate transporters as targets and mediators in cancer therapy response. Histol Histopathol 29(12):1511–1524. doi:10.14670/HH-29.1511
Morais-Santos F, Miranda-Goncalves V, Pinheiro S, Vieira AF, Paredes J, Schmitt FC, Baltazar F, Pinheiro C (2014) Differential sensitivities to lactate transport inhibitors of breast cancer cell lines. Endocr Relat Cancer 21(1):27–38. doi:10.1530/erc-13-0132
Morais-Santos F, Granja S, Miranda-Goncalves V, Moreira AH, Queiros S, Vilaca JL, Schmitt FC, Longatto-Filho A, Paredes J, Baltazar F, Pinheiro C (2015) Targeting lactate transport suppresses in vivo breast tumour growth. Oncotarget 6(22):19177–19189. doi:10.18632/oncotarget.3910
Kim JH, Kim SH, Alfieri AA, Young CW (1984) Quercetin, an inhibitor of lactate transport and a hyperthermic sensitizer of HeLa cells. Cancer Res 44(1):102–106
Volk C, Kempski B, Kempski OS (1997) Inhibition of lactate export by quercetin acidifies rat glial cells in vitro. Neurosci Lett 223(2):121–124. doi:10.1016/S0304-3940(97)13420-6
Wang Q, Morris ME (2007) Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. Drug Metab Dispos 35(2):201–208. doi:10.1124/dmd.106.012369
Hong CS, Graham NA, Gu W, Espindola Camacho C, Mah V, Maresh EL, Alavi M, Bagryanova L, Krotee PA, Gardner BK, Behbahan IS, Horvath S, Chia D, Mellinghoff IK, Hurvitz SA, Dubinett SM, Critchlow SE, Kurdistani SK, Goodglick L, Braas D, Graeber TG, Christofk HR (2016) MCT1 modulates cancer cell pyruvate export and growth of tumors that co-express MCT1 and MCT4. Cell Rep 14(7):1590–1601. doi:10.1016/j.celrep.2016.01.057
Harris T, Eliyahu G, Frydman L, Degani H (2009) Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells. Proc Natl Acad Sci USA 106(43):18131–18136. doi:10.1073/pnas.0909049106
Negrão R, Faria A (2009) Natural polyphenols as anti-oxidant, anti-inflammatory and anti-angiogenic agents in the metabolic syndrome. In: Soares R, Costa C (eds) Oxidative stress, inflammation and angiogenesis in the metabolic syndrome, 1st edn. Springer, Dordrecht, pp 147–180
Acknowledgments
This work was funded by Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal (Plano estratégico UID/BIM/04293/2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that no competing financial interests exist and that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Martel, F., Guedes, M. & Keating, E. Effect of polyphenols on glucose and lactate transport by breast cancer cells. Breast Cancer Res Treat 157, 1–11 (2016). https://doi.org/10.1007/s10549-016-3794-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-016-3794-z